Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-monthly intravenous C.E.R.A. maintenance study in dialysis patients with chronic renal anemia
2006-005621-28Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta in anemia of renal disease and chronic kidney disease (CKD), sponsored by Roche. Primary endpoint: Maintenance of hemoglobin levels. Started Dec 2007; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-005621-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005621-28.